Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.70
+2.5%
$94.46
$81.97
$139.06
$152.75B0.6311.87 million shs10.56 million shs
Lonza Group Ag stock logo
LZAGY
Lonza Group
$63.33
-1.0%
$63.04
$58.53
$73.85
$44.48B1.1488,873 shs54,776 shs
Medtronic PLC stock logo
MDT
Medtronic
$73.95
+0.2%
$82.36
$73.67
$106.33
$94.94B0.588.99 million shs14.20 million shs
Stryker Corporation stock logo
SYK
Stryker
$299.15
-1.9%
$321.82
$281.00
$404.87
$114.68B0.782.30 million shs2.95 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-2.36%-5.94%-25.26%-36.15%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.00%+1.83%+4.17%-5.92%-7.44%
Medtronic PLC stock logo
MDT
Medtronic
0.00%-6.27%-9.06%-24.83%-11.20%
Stryker Corporation stock logo
SYK
Stryker
0.00%-3.37%-2.83%-21.11%-20.14%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$87.70
+2.5%
$94.46
$81.97
$139.06
$152.75B0.6311.87 million shs10.56 million shs
Lonza Group Ag stock logo
LZAGY
Lonza Group
$63.33
-1.0%
$63.04
$58.53
$73.85
$44.48B1.1488,873 shs54,776 shs
Medtronic PLC stock logo
MDT
Medtronic
$73.95
+0.2%
$82.36
$73.67
$106.33
$94.94B0.588.99 million shs14.20 million shs
Stryker Corporation stock logo
SYK
Stryker
$299.15
-1.9%
$321.82
$281.00
$404.87
$114.68B0.782.30 million shs2.95 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-2.36%-5.94%-25.26%-36.15%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.00%+1.83%+4.17%-5.92%-7.44%
Medtronic PLC stock logo
MDT
Medtronic
0.00%-6.27%-9.06%-24.83%-11.20%
Stryker Corporation stock logo
SYK
Stryker
0.00%-3.37%-2.83%-21.11%-20.14%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.0935.79% Upside
Lonza Group Ag stock logo
LZAGY
Lonza Group
2.50
Moderate BuyN/AN/A
Medtronic PLC stock logo
MDT
Medtronic
2.58
Moderate Buy$106.4543.95% Upside
Stryker Corporation stock logo
SYK
Stryker
2.73
Moderate Buy$395.4832.20% Upside

Current Analyst Ratings Breakdown

Latest LZAGY, ABT, SYK, and MDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$121.00 ➝ $113.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
DowngradeHold (C+)Hold (C)
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
Set Price TargetNeutral$84.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
UpgradeHold$84.00
5/4/2026
Stryker Corporation stock logo
SYK
Stryker
DowngradeHold (C+)Hold (C)
5/4/2026
Stryker Corporation stock logo
SYK
Stryker
Reiterated RatingHold$380.00 ➝ $330.00
5/4/2026
Stryker Corporation stock logo
SYK
Stryker
Lower Price TargetOverweight$469.00 ➝ $394.00
5/1/2026
Stryker Corporation stock logo
SYK
Stryker
Reiterated RatingNeutral$361.00
5/1/2026
Stryker Corporation stock logo
SYK
Stryker
Set Price Target$410.00
5/1/2026
Stryker Corporation stock logo
SYK
Stryker
Set Price Target$385.00
5/1/2026
Stryker Corporation stock logo
SYK
Stryker
Set Price Target$355.00
(Data available from 6/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.45$7.16 per share12.24$30.35 per share2.89
Lonza Group Ag stock logo
LZAGY
Lonza Group
$7.88B5.64$1.97 per share32.21$15.79 per share4.01
Medtronic PLC stock logo
MDT
Medtronic
$33.54B2.83$7.77 per share9.52$37.62 per share1.97
Stryker Corporation stock logo
SYK
Stryker
$25.12B4.57$16.56 per share18.06$58.63 per share5.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5724.5714.471.4313.90%17.62%10.01%7/16/2026 (Estimated)
Lonza Group Ag stock logo
LZAGY
Lonza Group
$1.15BN/AN/A23.031.25N/AN/AN/A7/22/2026 (Estimated)
Medtronic PLC stock logo
MDT
Medtronic
$4.66B$3.5920.6012.161.7613.00%14.82%7.88%6/3/2026 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$3.25B$8.6434.6217.991.9213.20%23.42%11.04%7/30/2026 (Estimated)

Latest LZAGY, ABT, SYK, and MDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2026Q4 2026
Medtronic PLC stock logo
MDT
Medtronic
$1.54N/AN/AN/A$9.62 billionN/A
4/30/2026Q1 2026
Stryker Corporation stock logo
SYK
Stryker
$2.98$2.60-$0.38$1.93$6.34 billion$6.02 billion
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.87%+10.39%70.59%54 Years
Lonza Group Ag stock logo
LZAGY
Lonza Group
$0.140.22%N/AN/AN/A
Medtronic PLC stock logo
MDT
Medtronic
$2.843.84%+5.33%79.11%49 Years
Stryker Corporation stock logo
SYK
Stryker
$3.521.18%+7.58%40.74%32 Years

Latest LZAGY, ABT, SYK, and MDT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2026
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.881.2%6/30/20266/30/20267/31/2026
3/5/2026
Medtronic PLC stock logo
MDT
Medtronic
quarterly$0.713.26%3/27/20263/27/20264/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.42
2.24
1.77
Medtronic PLC stock logo
MDT
Medtronic
0.57
2.54
1.87
Stryker Corporation stock logo
SYK
Stryker
0.62
2.11
1.25

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.04%
Medtronic PLC stock logo
MDT
Medtronic
82.06%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Lonza Group Ag stock logo
LZAGY
Lonza Group
0.07%
Medtronic PLC stock logo
MDT
Medtronic
0.26%
Stryker Corporation stock logo
SYK
Stryker
4.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
Lonza Group Ag stock logo
LZAGY
Lonza Group
18,686702.29 million701.80 millionNot Optionable
Medtronic PLC stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable
Stryker Corporation stock logo
SYK
Stryker
56,000383.36 million365.73 millionOptionable

Recent News About These Companies

Is Stryker Stock Underperforming the S&P 500?
Robert Fletcher Sells 4,544 Shares of Stryker (NYSE:SYK) Stock
Citi Sticks to Its Buy Rating for Stryker (SYK)
Stryker (NYSE:SYK) VP Robert Fletcher Sells 4,544 Shares
Ronda Stryker Sells 310,000 Shares of Stryker (NYSE:SYK) Stock
Stryker: Reaching Interesting Levels
Stryker - Reaching Interesting Levels

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$87.70 +2.10 (+2.45%)
Closing price 03:59 PM Eastern
Extended Trading
$87.45 -0.25 (-0.28%)
As of 06:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Lonza Group stock logo

Lonza Group OTCMKTS:LZAGY

$63.33 -0.66 (-1.03%)
As of 03:59 PM Eastern

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.

Medtronic stock logo

Medtronic NYSE:MDT

$73.95 +0.14 (+0.19%)
Closing price 03:59 PM Eastern
Extended Trading
$74.14 +0.19 (+0.25%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker stock logo

Stryker NYSE:SYK

$299.14 -5.95 (-1.95%)
Closing price 03:59 PM Eastern
Extended Trading
$302.50 +3.35 (+1.12%)
As of 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.